# Phase I Study of PSD502 (Lidocaine Prilocaine Spray) Applied to the Glans Penis up to Three Times a Day for 21 Days in Healthy Male Volunteers

> **NCT00483990** · PHASE1 · COMPLETED · sponsor: **Plethora Solutions Ltd** · enrollment: 16 (—)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PSD502

## Key facts

- **NCT ID:** NCT00483990
- **Lead sponsor:** Plethora Solutions Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2007-06
- **Final completion:** 2007-06
- **Target enrollment:** 16 (—)
- **Last updated:** 2010-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00483990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00483990, "Phase I Study of PSD502 (Lidocaine Prilocaine Spray) Applied to the Glans Penis up to Three Times a Day for 21 Days in Healthy Male Volunteers". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00483990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*